Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Thuja Capital

Investor type Micro VC
Founders Harrold van Barlingen


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 48
Average round size
The average size of a deal this fund participated in
Portfolio companies 34
Rounds per year 3.00
Lead investments 27
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 14
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Therapeutics

In 2006 was created Thuja Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Utrecht. The venture was found in Europe in The Netherlands.

The common things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Thuja Capital works on 6 percentage points more the average amount of lead investments. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Thuja Capital, startups are often financed by AlpInvest Partners, Oxford Bioscience Partners, Global Life Science Ventures. The meaningful sponsors for the fund in investment in the same round are BOM Capital, Health Innovation Fund, DSM Venturing. In the next rounds fund is usually obtained by Van Herk Ventures, EASME - EU Executive Agency for SMEs, BOM Capital.

The current fund was established by Harrold van Barlingen. Besides them, we counted 2 critical employees of this fund in our database.

The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Curacyte AG, Drug Abuse Sciences, Salvia BioElectronics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Thuja Capital:
Typical Co-investors
Thuja Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Thuja Capital:

Funds with similar focus

Funds from The Netherlands
Funds with similar focus located in The Netherlands:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Life Science
$8M22 Mar 2022 Eindhoven, Noord-Brabant, The Netherlands

Synerkine Pharma

Health Care
$4M16 Dec 2021 Utrecht, Utrecht, Netherlands

ATRO Medical

Health Care
Medical Device
$2M14 Dec 2021 Nijmegen, Gelderland, Netherlands

Alveron Pharma

Emergency Medicine
$4M11 Oct 2021 Nijmegen, Gelderland, The Netherlands

Kinetyx Sciences Inc.

Information Technology
$3M28 Apr 2021 Calgary, Canada

Salvia BioElectronics

Medical Device
$31M22 Sep 2020 Eindhoven, North Brabant, Netherlands


Food and Beverage
Food Processing
Health Care
Organic Food
$7M30 Aug 2020 Gelderland

Indigo Diabetes

Health Care
Medical Device
$44M27 Jul 2020 East Flanders

Synerkine Pharma

Health Care
$3M25 Mar 2019 Utrecht


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Thuja Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: